Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,184 | 50,601 | 71,639 | 27,176 | 28,568 |
| Receivables | 613 | 503 | 235 | 540 | 782 |
| Inventories | 5,020 | 5,023 | 5,074 | 3,720 | 3,329 |
| TOTAL | $42,250 | $59,925 | $80,515 | $33,746 | $35,614 |
| Non-Current Assets | |||||
| PPE Net | 5,000 | 5,148 | 5,478 | 5,838 | 6,294 |
| Other Non-Current Assets | 8,006 | 8,213 | 7,730 | 7,655 | 7,324 |
| TOTAL | $13,006 | $13,361 | $13,208 | $13,493 | $13,618 |
| Total Assets | $55,256 | $73,286 | $93,723 | $47,239 | $49,232 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,152 | 2,527 | 3,155 | 1,216 | 471 |
| Accounts payable and accrued liabilities | 6,444 | 4,604 | 5,051 | 10,364 | 11,344 |
| Accrued Expenses | 11,906 | 9,543 | 9,469 | 7,854 | 9,890 |
| Other current liabilities | 393 | 393 | 1,384 | 1,095 | 876 |
| TOTAL | $23,794 | $18,110 | $20,069 | $20,529 | $22,581 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,398 | 10,861 | 10,152 | 7,126 | 7,733 |
| Deferred Revenues | 899 | 1,043 | 1,010 | N/A | N/A |
| Other Non-Current Liabilities | 6,172 | 6,373 | 5,883 | 5,876 | 6,023 |
| TOTAL | $16,889 | $18,490 | $17,435 | $12,862 | $13,547 |
| Total Liabilities | $40,683 | $36,600 | $37,504 | $33,391 | $36,128 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,993 | 14,983 | 14,964 | 12,988 | 11,478 |
| Common Shares | 1,953,916 | 1,942,989 | 1,933,305 | 1,900,746 | 1,877,099 |
| Retained earnings | -1,936,104 | -1,908,705 | -1,879,703 | -1,889,899 | -1,867,455 |
| Other shareholders' equity | -3,239 | 2,402 | 2,617 | 3,001 | 3,460 |
| TOTAL | $14,573 | $36,686 | $56,219 | $13,848 | $13,104 |
| Total Liabilities And Equity | $55,256 | $73,286 | $93,723 | $47,239 | $49,232 |